Novartis AG is 39.3x more valuable than Praxis Precision Medicines, Inc. by market capitalization ($292.08 B vs $7.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PRAX | NVS |
|---|---|---|
| Market cap | $7.43 B | $292.08 B |
| US-listed rank | #1126 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$303.00M | - |
| SEC filings | 474 | 947 |
Novartis AG is 39.3x more valuable than Praxis Precision Medicines, Inc. by market capitalization ($292.08 B vs $7.43 B).
Full pages: Praxis Precision Medicines, Inc. and Novartis AG, or browse the full rankings.